Retaining Genentech Is Key to Bay Area Retaining Its Biocluster Status

The San Francisco Bay Area must also build ties with Asian biopharma companies and their executives and investors, according to Scott Morrison, national leader for Ernst & Young's life-sciences practice.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.